Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-08-31

FDA Approved: VEOZAH — Supplemental Application (Astellas Pharma US, Inc.)

View source ↗

Summary

FDA approved a supplemental application for VEOZAH (fezolinetant) submitted by Astellas Pharma US, Inc. The action updates the product labeling to reflect the c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VEOZAH (fezolinetant)

Snippet

SUPPL AP for VEOZAH (FEZOLINETANT)